As of 2024-12-13, the Relative Valuation of XSpray Pharma AB (publ) (XSPRAY.ST) is (109.78) SEK. This relative valuation is based on P/E multiples. With the latest stock price at 44.45 SEK, the upside of XSpray Pharma AB (publ) based on Relative Valuation is -347.0%.
The range of the Relative Valuation is (112.56) - (141.05) SEK.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.2x - 21.5x | 18.8x |
| Forward P/E multiples | 5.2x - 20.3x | 12.8x |
| Fair Price | (112.56) - (141.05) | (109.78) |
| Upside | -353.2% - -417.3% | -347.0% |
| Date | P/E |
| 2024-11-29 | -5.96 |
| 2024-11-28 | -6.12 |
| 2024-11-27 | -6.04 |
| 2024-11-26 | -6.06 |
| 2024-11-25 | -6.07 |
| 2024-11-22 | -5.94 |
| 2024-11-21 | -5.97 |
| 2024-11-20 | -6.07 |
| 2024-11-19 | -5.94 |
| 2024-11-18 | -6.10 |
| 2024-11-15 | -6.25 |
| 2024-11-14 | -6.33 |
| 2024-11-13 | -6.31 |
| 2024-11-12 | -6.22 |
| 2024-11-11 | -6.54 |
| 2024-11-08 | -6.74 |
| 2024-11-07 | -6.86 |
| 2024-11-06 | -6.97 |
| 2024-11-05 | -8.13 |
| 2024-11-04 | -8.39 |
| 2024-11-01 | -8.62 |
| 2024-10-31 | -8.62 |
| 2024-10-30 | -8.65 |
| 2024-10-29 | -8.65 |
| 2024-10-28 | -8.56 |
| 2024-10-25 | -8.29 |
| 2024-10-24 | -8.61 |
| 2024-10-23 | -8.64 |
| 2024-10-22 | -8.56 |
| 2024-10-21 | -8.92 |
| 2024-10-18 | -8.75 |
| 2024-10-17 | -8.06 |
| 2024-10-16 | -7.66 |
| 2024-10-15 | -7.51 |
| 2024-10-14 | -7.27 |
| 2024-10-11 | -7.17 |
| 2024-10-10 | -7.02 |
| 2024-10-09 | -6.79 |
| 2024-10-08 | -6.86 |
| 2024-10-07 | -6.98 |
| 2024-10-04 | -6.96 |
| 2024-10-03 | -6.86 |
| 2024-10-02 | -6.92 |
| 2024-10-01 | -7.17 |
| 2024-09-30 | -7.14 |
| 2024-09-27 | -7.31 |
| 2024-09-26 | -7.22 |
| 2024-09-25 | -7.34 |
| 2024-09-24 | -6.91 |
| 2024-09-23 | -7.02 |